NCT01332214View on ClinicalTrials.gov

To Assess the Safety, Tolerability and Pharmacokinetics of AZD2820 After Single Ascending Doses

PHASE1CompletedINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions

Healthy

Interventions

DRUG

AZD2820

Subcutaneous Injection in abdomen or Thigh

DRUG

Placebo

Subcutaneous Injection in abdomen or Thigh

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY